| Literature DB >> 26835197 |
Ralph J Mobbs1, Kevin Phan1, Ganesha K Thayaparan2, Prashanth J Rao1.
Abstract
Study Design Retrospective analysis of prospectively collected observational data. Objective To assess the safety and efficacy of anterior lumbar interbody fusion (ALIF) as a salvage option for lumbar pseudarthrosis following failed posterior lumbar fusion surgery. Methods From 2009 to 2013, patient outcome data was collected prospectively over 5 years from 327 patients undergoing ALIF performed by a single surgeon (R.J.M.) with 478 levels performed. Among these, there were 20 cases of failed prior posterior fusion that subsequently underwent ALIF. Visual analog score (VAS), Oswestry Disability Index (ODI), and Short Form 12-item health survey (SF-12) were measured pre- and postoperatively. The verification of fusion was determined by utilizing a fine-cut computed tomography scan at 12-month follow-up. Results There was a significant difference between the preoperative (7.25 ± 0.8) and postoperative (3.1 ± 2.1) VAS scores (p < 0.0001). The ODI scale also demonstrated a statistically significant reduction from preoperative (56.3 ± 16.5) and postoperative (30.4 ± 19.3) scores (p < 0.0001). The SF-12 scores were significantly improved after ALIF salvage surgery: Physical Health Composite Score (32.18 ± 5.5 versus 41.07 ± 9.67, p = 0.0003) and Mental Health Composite Score (36.62 ± 12.25 versus 50.89 ± 10.86, p = 0.0001). Overall, 19 patients (95%) achieved successful fusion. Conclusions Overall, our results suggest that the ALIF procedure results not only in radiographic improvements in bony fusion but in significant improvements in the patient's physical and mental experience of pain secondary to lumbar pseudarthrosis. Future multicenter registry studies and randomized controlled trials should be conducted to confirm the long-term benefit of ALIF as a salvage option for failed posterior lumbar fusion.Entities:
Keywords: ALIF; anterior lumbar interbody fusion; nonunion; posterior lumbar fusion; pseudarthrosis
Year: 2015 PMID: 26835197 PMCID: PMC4733375 DOI: 10.1055/s-0035-1555656
Source DB: PubMed Journal: Global Spine J ISSN: 2192-5682
Baseline characteristics of included patients
| Patient | Gender | Age (y) | WC | DM | Smoker | Time to revision (mo) | Level | Number of levels | Bone graft (conductive) | Bone graft (inductive) | Fusion | Complications | Infections |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 78 | N | N | N | 15 | L5–S1 | 1 | iF | iF | Y | N | N |
| 2 | M | 47 | N | N | N | 18 | L5–S1 | 1 | iF | iF | Y | N | N |
| 3 | F | 46 | N | N | N | 9 | L3–4 | 1 | Alo | IN | Y | N | N |
| 4 | M | 63 | Y | N | N | 15 | L5–S1 | 1 | iF | iF | N | N | N |
| 5 | F | 63 | N | N | N | 12 | L4–5 + L5–S1 | 2 | iF | iF | Y | Hernia | N |
| 6 | F | 67 | N | N | N | 18 | L5–S1 | 1 | Alo | IN | Y | N | N |
| 7 | M | 52 | N | N | N | 18 | L3–4 + L4–5 | 2 | iF | iF | Y | N | N |
| 8 | M | 48 | Y | N | Y | 24 | L5–S1 | 1 | iF | iF | Y | N | N |
| 9 | M | 41 | Y | N | Y | 24 | L5–S1 | 1 | Alo | IN | Y | N | N |
| 10 | M | 64 | N | Y | N | 18 | L3-S1 | 3 | Alo | IN | Y | N | N |
| 11 | M | 65 | N | Y | N | 18 | L5–S1 | 1 | iF | iF | Y | N | N |
| 12 | M | 42 | Y | N | Y | 12 | L5–S1 | 1 | Alo | IN | Y | N | N |
| 13 | M | 58 | N | N | N | 20 | L3–4 | 1 | iF | iF | Y | N | N |
| 14 | F | 67 | N | Y | N | 18 | L4–5 | 1 | Alo | IN | Y | N | N |
| 15 | M | 38 | N | N | Y | 12 | L4–5 | 1 | Alo | IN | Y | N | N |
| 16 | F | 47 | N | N | Y | 18 | L4–5 + L5–S1 | 2 | Alo | IN | Y | Post op hematuria | N |
| 17 | F | 32 | N | N | N | 9 | L4–5 | 1 | Aut | Aut | Y | N | N |
| 18 | F | 59 | N | N | N | 36 | L5–S1 | 1 | Alo | IN | Y | N | N |
| 19 | F | 81 | N | N | N | 12 | L4–5 | 1 | Alo | OP1 | Y | N | N |
| 20 | F | 59 | N | N | N | 24 | L5–S1 | 1 | Alo | OP1 | Y | N | N |
| Total | 10 (50%) | 56 (32–81) | 4 (20%) | 3 (15%) | 5 (25%) | 17.5 (9–36) | – | 27 | – | – | 19 (95%) | 2 (10%) | 0 (%) |
Abbreviations: Alo, allograft; Aut, autograft; DM, diabetes mellitus; IN, INFUSE (Medtronic, Memphis, TN, United States); N, no; iF, iFactor (Cerapedics, Inc., Denver, CO, United States), OP1, osteogenic protein 1 (Stryker, Boston, MA, United States); WC, worker's compensation; Y, yes.
Average (range).
Fig. 1Preoperative versus postoperative visual analog score (VAS) for back pain following anterior lumbar interbody fusion revision surgery.
Fig. 2Preoperative versus postoperative Oswestry Disability Index (ODI) scores following anterior lumbar interbody fusion revision surgery.
Fig. 3Preoperative versus postoperative Short Form 12-item health survey (SF-12) scores following anterior lumbar interbody fusion revision surgery. Significantly higher postoperative SF-12 PCS scores and MCS scores were observed postoperatively compared to preoperative scores. PCS, Physical Health Composite Score; MCS, Mental Health Composite Score.
Fig. 4Revision anterior lumbar interbody fusion performed 18 months after initial L3–L4 posterior onlay fusion. Arrow demonstrates lack of bone union across the motion segment.
Fig. 5Sequence of events with nonunion. A 56-year-old woman presented with nonunion following minimally invasive transforaminal lumbar interbody fusion (TLIF) at L3–L4. (A) TLIF cage with no bone integration through implant. (B) Intraoperative X-ray demonstrating removal of TLIF cage and insertion of Synfix (Synthes Bettlach, Bettlach, Switzerland) anterior lumbar interbody fusion (ALIF). (C) Solid union of the L3–L4 motion segment can be seen at 12 months post-ALIF.
Fig. 6Utility of anterior lumbar interbody fusion (ALIF) for multilevel nonunion. (A) X-ray of multilevel posterior onlay fusion. (B) Intraoperative X-ray with three-level ALIF implants. (C) Computed tomography scan 12 months postoperatively with solid union through all three levels.